Corrections Noted in Table 2 of the Melanoma Self Surveillance Trial Article

May 1, 2026

Jama Dermatology

1

Errors were identified in Table 2 of the Melanoma Self Surveillance Trial article.
2

The percentages for the perceived chance of developing a new melanoma were switched.
3

Two figures were missing from Supplement 3 of the original article.
4

The corrections were published online on March 11, 2026.
5

The article was originally titled 'Characteristics of Participants Screened and Randomized to the Melanoma Self Surveillance Trial.'.

Original Source(s)

Jama Dermatology

Related Content

Retinal Physician

Ocular tumor coding can be challenging because ocular oncology often involves evolving lesions, diagnostic uncertainty, and terminology that does not always translate cleanly into ICD-10-CM codes. Understanding how to distinguish benign, malignant, in situ, and uncertain histologic behavior neoplasms is essential for accurate coding, medical necessity, and audit defensibility.